Abbott Laboratories Forecast, price target & analysts
Abbott Laboratories Target price 2026 - Analyst rating & recommendation
Abbott Laboratories Classifications & Recommendation
Abbott Laboratories Price Target
| Target Price | $122.40 |
| Price | $97.50 |
| Potential |
25.54%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Abbott Laboratories 2027 .
The average Abbott Laboratories target price is $122.40.
This is
25.54%
register free of charge
$142.80
46.46%
register free of charge
$104.03
6.70%
register free of charge
|
|
| A rating was issued by 33 analysts: 25 Analysts recommend Abbott Laboratories to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Abbott Laboratories stock has an average upside potential 2027 of
25.54%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 44.33 | 50.70 |
| 5.67% | 14.38% | |
| EBITDA Margin | 22.58% | 26.53% |
| 6.78% | 17.50% | |
| Net Margin | 14.72% | 19.03% |
| 53.93% | 29.30% |
31 Analysts have issued a sales forecast Abbott Laboratories 2026 . The average Abbott Laboratories sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Abbott Laboratories EBITDA forecast 2026. The average Abbott Laboratories EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
31 Abbott Laboratories Analysts have issued a net profit forecast 2026. The average Abbott Laboratories net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.73 | 5.58 |
| 51.37% | 49.60% | |
| P/E | 17.48 | |
| EV/Sales | 3.86 |
31 Analysts have issued a Abbott Laboratories forecast for earnings per share. The average Abbott Laboratories EPS is
This results in the following potential growth metrics and future valuations:
Abbott Laboratories...
Current Abbott Laboratories Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD Cowen |
Locked
➜
Locked
|
Locked | Sep 08 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 25 2026 |
| Wolfe Research |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Jul 17 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD Cowen:
Locked
➜
Locked
|
Sep 08 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 25 2026 |
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 17 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 17 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
